Monte Rosa Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 09, 2023 at 07:27 am EST
Monte Rosa Therapeutics, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was USD 34.88 million compared to USD 27.32 million a year ago. Basic loss per share from continuing operations was USD 0.7 compared to USD 0.58 a year ago.
For the nine months, net loss was USD 102.1 million compared to USD 77.72 million a year ago. Basic loss per share from continuing operations was USD 2.06 compared to USD 1.67 a year ago.